Interferon for ocular surface squamous neoplasia in 81 cases: Outcomes based on the american joint committee on cancer classification

Cornea

Volumn 32, Issue 3, 2013, Pages 248-256

  Shields, Carol L ^a   Kaliki, Swathi ^a   Kim, H Jane ^a   Al Dahmash, Saad ^a,b   Shah, Sanket U ^a   Lally, Sara E ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

American Joint Committee on Cancer; conjunctiva; eye; interferon alpha 2b; ocular surface squamous neoplasia; squamous cell carcinoma; topical chemotherapy; tumor

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MITOMYCIN; RECOMBINANT ALPHA2B INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER SURGERY; CHILD; CONJUNCTIVA DISEASE; CONJUNCTIVA FOLLICLE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORNEA STEM CELL LOSS; CRYOTHERAPY; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; EYE IRRITATION; EYE SURGERY; EYE TUMOR; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OCULAR SURFACE DISEASE; OCULAR SURFACE SQUAMOUS NEOPLASIA; OUTCOME ASSESSMENT; PERFORATING EYE INJURY; PRIORITY JOURNAL; PUNCTAL STENOSIS; PUNCTATE KERATITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLERA PERFORATION; SIDE EFFECT; TOPICAL TREATMENT; TREATMENT PLANNING; TUMOR RECURRENCE; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CHILD; COMBINED MODALITY THERAPY; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; INJECTIONS; INTERFERON-ALPHA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84873990987     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182523f61     Document Type: Article

References (30)

1. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49:3-24.
2. Shields CL, Demirci H, Karatza E, et al. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004; 111:1747-1754.
3. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
4. Shields JA, Shields CL. Eyelid, Conjunctival, and Orbital Tumors. An Atlas and Textbook. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:286-306.
5. Ramasubramanian A, Shields CL, Sinha N, et al. Ocular surface squamous neoplasia after corneal graft. Am J Ophthalmol. 2010;149:62-65.
6. Shields CL, Ramasubramanian A, Mellen PL, et al. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection). Ophthalmology. 2011;118:2133-2137.
7. Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin Ophthalmol. 2006;21:161-169.
8. Hirst LW. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Ophthalmology. 2007;114: 976-982.
9. Sepulveda R, Péer J, Midena E, et al. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol. 2010;94: 532-535.
10. Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107:2190-2195.
11. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601-606.
12. Shields CL, Demirci H, Marr BP, et al. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol. 2005;123:109-113.
13. Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106: 91-97.
14. Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1093-1098.
15. Schechter BA, Schrier A, Nagler RS, et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21:6-11.
16. Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology. 2004;111:1755-1761.
17. Esquenazi S, Fry CL, Holley E. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b. Br J Ophthalmol. 2005;89:1221.
18. Nemet AY, Sharma V, Benger R. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Clin Experiment Ophthalmol. 2006;34: 375-377.
19. Holcombe DJ, Lee GA. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol. 2006; 142:568-571.
20. Sturges A, Butt AL, Lai JE, et al. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology. 2008;115:1297-1302.
21. Schechter BA, Koreishi AF, Karp CL, et al. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology. 2008;115:1291-1296.
22. Galor A, Karp CL, Chhabra S, et al. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94:551-554.
23. Karp CL, Galor A, Chhabra S, et al. Subconjunctival/perilesional recombinant interferon a2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117:2241-2246.
24. Shah SU, Kaliki S, Kim HJ, et al. Topical interferon alpha-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Arch Ophthalmol. 2012;130:159-164.
25. Kim HJ, Shields CL, Shah SU, et al. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Ophthalmology. [published online ahead of print February 21, 2012] doi:10.1016/j.ophtha.2011.11.035.
26. Edge SB, Byrd DR, Compton CC, et al. Carcinoma of the conjunctiva. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 531-537.
27. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997;115:808-815.
28. Edge SB, Byrd DR, Comptom CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
29. Shields JA, Shields CL, Gunduz K, et al. The 1998 Pan American Lecture. Intraocular invasion of conjunctival squamous cell carcinoma in five patients. Ophthal Plast Reconstr Surg. 1999;15:153-160.
30. Smith M, Trousdale MD, Rao NA, et al. Lack of toxicity of a topical recombinant interferon alpha. Cornea. 1989;8:58-61.